Socioeconomics and Retinal Care: Reaching Those At Risk -

Socioeconomics and Retinal Care Reaching Those At Risk

Media formats available:

Details

Presenters

Overview
This live virtual symposium will cover timely issues about race and socioeconomics and how they affect patient care. The faculty will discuss access to care, disease awareness among patients with the highest risk factors, and treatment noncompliance, among other topics. The experts in retinal disease will also share their experience with these issues and potential solutions through case studies and discussions with audience members.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Discuss how ethnicity and socioeconomics impacts patient awareness of the ocular complications of diabetes
- Explain the efficacy of current treatment options in specific populations
- Develop individualized plans for patients with diabetic eye disease who may be at higher risk for progression due to nonadherence
- Apply case study examples to clinical settings
Accreditation
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Ankoor R. Shah, MD
Program Chair
Retina Consultants of Texas
Houston, TX

John W. Kitchens, MD
Partner
Retina Associates of Kentucky
Lexington, KY

Nancy Holekamp, MD
Director of Retina Services
Pepose Vision Institute
Chesterfield, MO

Yoshihiro Yonekawa, MD
Adult and Pediatric Vitreoretinal Surgery
Mid Atlantic Retina
Wills Eye Hospital
Philadelphia, PA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Ankoor R. Shah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Novartis and Ocular Therapeutix.
John W. Kitchens, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Alimera, Allergan, Bayer, Carl Zeiss Meditec, Genentech, Kodiak Sciences, and Regeneron Pharmaceuticals. Grant/Research Support: Kodiak Sciences. Speaker's Bureau: Bayer, Genentech, and Regeneron Pharmaceuticals.
Nancy Holekamp, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Bayer, Lineage Cell Therapeutics, Clearside Biosciences, Gemini, Gyroscope, Katalyst Surgical, Nacuity, Notal Vision, Novartis, Polyactiva, and Regeneron Pharmaceuticals. Grant/Research Support: Genentech, Gemini, Gyroscope, Notal Vision. Speaker's Bureau: Allergan, Genentech, Novartis, Regeneron Pharmaceuticals, and Spark Therapeutics. Shareholder: Katalyst Surgical.
Yoshihiro Yonekawa, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Alimera, Allergan, and Genentech.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 06/08/2021
Expiration Date: 06/17/2021

Yoshihiro Yonekawa, MD

Yoshihiro Yonekawa, MD

Ankoor R. Shah, MD

Ankoor R. Shah, MD

John W. Kitchens, MD

John W. Kitchens, MD

Nancy Holekamp, MD

Nancy Holekamp, MD

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!